HOME >> BIOLOGY >> NEWS
1st evidence that nuclear transplantation ('therapeutic cloning') can eliminate tissue rejection

Worcester, MA June 3, 2002 Advanced Cell Technology, Inc. (ACT) reported today that nuclear transplantation can be used to generate functional immune-compatible tissues. The research, which will appear in the July issue (cover story) of Nature Biotechnology, by ACT and its collaborators, provides the first experimental evidence that it may be possible to use cloning to generate medically important tissues and eliminate tissue rejection. Heart 'patches' and miniature kidneys engineered from cloned cells were successfully tested in a large-animal model, the cow, which has a sophisticated immune system similar to that of humans.

"These results bode well for the future of human therapeutic cloning," said Robert Lanza, Vice President of Medical & Scientific Development at ACT, and lead author of the study. "Cloning could theoretically provide a limitless supply of cells and organs for any type of regenerative therapy. Before now, therapeutic cloning as a means of preventing rejection was criticized by some as being purely theoretical just an idea. This study furnishes the first scientific evidence that cloned tissues can be transplanted back into animals without being destroyed by the body's immune system. The use in medicine to generate immune-compatible cells using cloning would overcome one of the major scientific challenges in transplantation medicine - namely, the problem of organ and tissue rejection."

The goal of nuclear transplantation is to clone genetically matched cells and organs for transplantation into patients suffering from a wide range of disorders that result from tissue loss or dysfunction. In addition to patients with heart, lung, liver and/or kidney disease, millions more suffer from diabetes, arthritis, AIDS, strokes, cancer and other diseases that may one day be treatable using this technology. It has been estimated that by the year 2010 over 2 million patients will suffer from end-stage kidney disease alone, at an aggregate c
'"/>


2-Jun-2002


Page: 1 2 3

Related biology news :

1. New evidence of radiation risk in childhood leukaemia
2. Oldest evidence for processing of wild cereals: starch grains from barley, wheat, on grinding stone
3. Earliest evidence of hereditary genetic disorder discovered by Hebrew University researchers
4. Study finds first evidence COX-2 enzymes can regulate DNA damage
5. Researchers find evidence that sea turtles navigate with magnetic maps
6. Researchers report definitive evidence that HIV-AIDS is not from oral polio vaccine
7. Oldest known evidence of cat taming found in Cyprus, researchers report in Science
8. More evidence of major global extinctions
9. New evidence points to pollution as main cause of much coral reef destruction
10. New evidence suggests that monkey thought extinct still exists
11. Earliest evidence of humans affecting aquatic ecology in Canada, United States

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/12/2019)... (PRWEB) , ... November 12, 2019 , ... ... Cross-Channel Spend Optimizer that improves digital advertising performance up to 25% and reduces ... Advertising, Cross-Channel Spend Optimizer uses advanced multi-touch attribution (MTA) to predict best advertising ...
(Date:11/9/2019)... ... November 08, 2019 , ... SiteSeer Technologies, creator of ... as a new client and user of SiteSeer. The boutique real estate developer of ... U.S. will use SiteSeer to supplement its own analysis of markets. , Geoffrey ...
(Date:11/6/2019)... ... November 06, 2019 , ... In October, Massachusetts stem cell ... patients about a poorly disclosed deficiency in stem cell treatments. Throughout stem ... the treating stem cells. This problem affects all patients receiving stem cell ...
Breaking Biology News(10 mins):
(Date:11/19/2019)... ... November 19, 2019 , ... Supercomputing Conference ... learning infrastructure solutions for Autonomous Vehicle , Medical Imaging, and Natural Language ... systems with the Graphcore Poplar® software stack as part of its bare-metal cloud ...
(Date:11/12/2019)... ... November 12, 2019 , ... Genedata, ... that Immatics Biotechnologies , a clinical-stage biopharmaceutical company developing T-cell receptor ... R&D operations related to the discovery and development of high-affinity and high-specificity ...
(Date:11/12/2019)... Va. (PRWEB) , ... November 12, 2019 , ... ... forensic DNA services, welcomed their new Director of Forensic Genealogy, Melinde Lutz Byrne, ... Genealogy Service (FGS) to ultimately provide investigative leads to law enforcement through ...
(Date:11/9/2019)... ... November 08, 2019 , ... ... for use in pathology research, today announced the results of analyses examining ... enrolled in the phase 3 selonsertib studies (STELLAR). Strong correlations were demonstrated ...
Breaking Biology Technology:
Cached News: